miR-29a inhibits human retinoblastoma progression by targeting STAT3

Shu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Chunling Xu(Second Affiliated Hospital of Jilin University)
Oncology Reports
December 11, 2017
Cited by 31


Related Papers